{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:05:09Z","timestamp":1778940309207,"version":"3.51.4"},"reference-count":46,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2021]]},"DOI":"10.3960\/jslrt.21007","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T22:09:37Z","timestamp":1640124577000},"page":"202-209","source":"Crossref","is-referenced-by-count":13,"title":["Tumor microenvironment of adult T-cell leukemia\/lymphoma"],"prefix":"10.3960","volume":"61","author":[{"given":"Mai","family":"Takeuchi","sequence":"first","affiliation":[{"name":"Department of Pathology, Kurume University, Kurume, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University, Kurume, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University, Kurume, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Swerdlow SH, Campo E, Pileri SA et al.<\/i> The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127: 2375-2390.","DOI":"10.1182\/blood-2016-01-643569"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br J Haematol. 1991; 79: 428-437.","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Takasaki Y, Iwanaga M, Imaizumi Y et al.<\/i> Long-term study of indolent adult T-cell leukemia-lymphoma. Blood. 2010; 115: 4337-4343.","DOI":"10.1182\/blood-2009-09-242347"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Yamada Y. Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia\/lymphoma. Blood. 1983; 61: 192-199.","DOI":"10.1182\/blood.V61.1.192.192"},{"key":"5","unstructured":"5 Takatsuki K, Yamaguchi K, Watanabe T. Adult T-cell leukemia and HTLV-I related diseases. Gann Mono Can Res. 1992; 39: 1-15."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Karube K, Ohshima K, Tsuchiya T et al.<\/i> Expression of FoxP3, a key molecule in CD4 + CD25 + regulatory T cells, in adult T-cell leukaemia\/lymphoma cells. Br J Haematol. 2004; 126: 81-84.","DOI":"10.1111\/j.1365-2141.2004.04999.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Hicklin DJ, Wang Z, Arienti F et al.<\/i> beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma. J Clin Invest. 1998; 101: 2720-2729.","DOI":"10.1172\/JCI498"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Momburg F, M\u00f6ller P, Moldenhauer G, H\u00e4mmerling GJ. Loss of HLA-A,B,C in colorectal carcinoma is related to the degree of de-differentiation. J Immunogenet. 1986; 13: 195-199.","DOI":"10.1111\/j.1744-313X.1986.tb01101.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kataoka K, Nagata Y, Kitanaka A et al.<\/i> Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet. 2015; 47: 1304-1315.","DOI":"10.1038\/ng.3415"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Asano N, Miyoshi H, Kato T et al.<\/i> Expression pattern of immunosurveillance-related antigen in adult T cell leukaemia\/lymphoma. Histopathology. 2018; 72: 945-954.","DOI":"10.1111\/his.13461"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Sconocchia G, Eppenberger-Castori S, Zlobec I et al.<\/i> HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker. Neoplasia. 2014; 16: 31-42.","DOI":"10.1593\/neo.131568"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Esteban F, Ruiz-Cabello F, Concha A et al.<\/i> HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx. Clin Exp Metastasis. 1990; 8: 319-328.","DOI":"10.1007\/BF01810678"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Rimsza LM, Roberts RA, Miller TP et al.<\/i> Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood. 2004; 103: 4251-4258.","DOI":"10.1182\/blood-2003-07-2365"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 He Y, Rozeboom L, Rivard CJ et al.<\/i> MHC class II expression in lung cancer. Lung Cancer. 2017; 112: 75-80.","DOI":"10.1016\/j.lungcan.2017.07.030"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Hemon P, Jean-Louis F, Ramgolam K et al.<\/i> MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis. J Immunol. 2011; 186: 5173-5183.","DOI":"10.4049\/jimmunol.1002050"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Holling TM, Schooten E, Langerak AW, van den Elsen PJ. Regulation of MHC class II expression in human T-cell malignancies. Blood. 2004; 103: 1438-1444.","DOI":"10.1182\/blood-2003-05-1491"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Shirono K, Hattori T, Hata H, Nishimura H, Takatsuki K. Profiles of expression of activated cell antigens on peripheral blood and lymph node cells from different clinical stages of adult T-cell leukemia. Blood. 1989; 73: 1664-1671.","DOI":"10.1182\/blood.V73.6.1664.1664"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Takeuchi M, Miyoshi H, Asano N et al.<\/i> Human leukocyte antigen class II expression is a good prognostic factor in adult T-cell leukemia\/lymphoma. Haematologica. 2019; 104: 1626-1632.","DOI":"10.3324\/haematol.2018.205567"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Challa-Malladi M, Lieu YK, Califano O et al.<\/i> Combined genetic inactivation of \u03b22-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell. 2011; 20: 728-740.","DOI":"10.1016\/j.ccr.2011.11.006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Palomero T, Couronn\u00e9 L, Khiabanian H et al.<\/i> Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014; 46: 166-170.","DOI":"10.1038\/ng.2873"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Yoshida N, Karube K, Utsunomiya A et al.<\/i> Molecular characterization of chronic-type adult T-cell leukemia\/lymphoma. Cancer Res. 2014; 74: 6129-6138.","DOI":"10.1158\/0008-5472.CAN-14-0643"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kataoka K, Shiraishi Y, Takeda Y et al.<\/i> Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers. Nature. 2016; 534: 402-406.","DOI":"10.1038\/nature18294"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Miyoshi H, Kiyasu J, Kato T et al.<\/i> PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia\/lymphoma. Blood. 2016; 128: 1374-1381.","DOI":"10.1182\/blood-2016-02-698936"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Yasinska IM, Sakhnevych SS, Pavlova L et al.<\/i> The Tim-3-Galectin-9 pathway and its regulatory mechanisms in human breast cancer. Front Immunol. 2019; 10: 1594.","DOI":"10.3389\/fimmu.2019.01594"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Horlad H, Ohnishi K, Ma C et al.<\/i> TIM-3 expression in lymphoma cells predicts chemoresistance in patients with adult T-cell leukemia\/lymphoma. Oncol Lett. 2016; 12: 1519-1524.","DOI":"10.3892\/ol.2016.4774"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Takeuchi M, Miyoshi H, Nakashima K et al.<\/i> Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia\/lymphoma. Ann Hematol. 2020; 99: 1093-1098.","DOI":"10.1007\/s00277-020-03967-x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Fu Y, Lin Q, Zhang Z, Zhang L. Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity. Acta Pharm Sin B. 2020; 10: 414-433.","DOI":"10.1016\/j.apsb.2019.08.010"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Saito M, Tanaka R, Arishima S et al.<\/i> Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis. Retrovirology. 2013; 10: 51.","DOI":"10.1186\/1742-4690-10-51"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Pentcheva-Hoang T, Egen JG, Wojnoonski K, Allison JP. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity. 2004; 21: 401-413.","DOI":"10.1016\/j.immuni.2004.06.017"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013; 13: 227-242.","DOI":"10.1038\/nri3405"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Vallois D, Dupuy A, Lemonnier F et al.<\/i> RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells. Haematologica. 2018; 103: e360-e363.","DOI":"10.3324\/haematol.2017.186767"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Yoshida N, Shigemori K, Donaldson N et al.<\/i> Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions. Blood. 2020; 135: 1467-1471.","DOI":"10.1182\/blood.2019001815"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Sakamoto Y, Ishida T, Masaki A et al.<\/i> Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia\/lymphoma. Br J Haematol. 2021; 192: 281-291.","DOI":"10.1111\/bjh.17211"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Hao NB, L\u00fc MH, Fan YH et al.<\/i> Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol. 2012; 2012: 948098.","DOI":"10.1155\/2012\/948098"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Komohara Y, Niino D, Saito Y et al.<\/i> Clinical significance of CD 163 + tumor-associated macrophages in patients with adult T-cell leukemia\/lymphoma. Cancer Sci. 2013; 104: 945-951.","DOI":"10.1111\/cas.12167"},{"key":"36","unstructured":"36 Li Y, Lu S, Xu Y et al.<\/i> Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma. Am J Transl Res. 2017; 9: 2901-2910."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Barrera L, Montes-Serv\u00edn E, Hernandez-Martinez JM et al.<\/i> CD47 overexpression is associated with decreased neutrophil apoptosis\/phagocytosis and poor prognosis in non-small-cell lung cancer patients. Br J Cancer. 2017; 117: 385-397.","DOI":"10.1038\/bjc.2017.173"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Yanagida E, Miyoshi H, Takeuchi M et al.<\/i> Clinicopathological analysis of immunohistochemical expression of CD47 and SIRP\u03b1 in adult T-cell leukemia\/lymphoma. Hematol Oncol. 2020; 38: 680-688.","DOI":"10.1002\/hon.2768"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Hasegawa H, Nomura T, Kohno M et al.<\/i> Increased chemokine receptor CCR7\/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood. 2000; 95: 30-38.","DOI":"10.1182\/blood.V95.1.30.001k09_30_38"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Shimizu K, Karube K, Arakawa F et al.<\/i> Upregulation of CC chemokine ligand 18 and downregulation of CX3C chemokine receptor 1 expression in human T-cell leukemia virus type 1-associated lymph node lesions: Results of chemokine and chemokine receptor DNA chip analysis. Cancer Sci. 2007; 98: 1875-1880.","DOI":"10.1111\/j.1349-7006.2007.00627.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Korbecki J, Olbromski M, Dzi\u0119giel P. CCL18 in the progression of cancer. Int J Mol Sci. 2020; 21: 7955.","DOI":"10.3390\/ijms21217955"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Nishimura M, Umehara H, Nakayama T et al.<\/i> Dual functions of fractalkine\/CX3C ligand 1 in trafficking of perforin+\/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol. 2002; 168: 6173-6180.","DOI":"10.4049\/jimmunol.168.12.6173"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Ratner L, Waldmann TA, Janakiram M, Brammer JE. Rapid progression of adult T-cell leukemia\u2013lymphoma after PD-1 inhibitor therapy. N Engl J Med. 2018; 378: 1947-1948.","DOI":"10.1056\/NEJMc1803181"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Ishitsuka K, Utsunomiya A, Ishida T. PD-1 inhibitor therapy in adult T-cell leukemia\u2013lymphoma. N Engl J Med. 2018; 379: 695-697.","DOI":"10.1056\/NEJMc1807852"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Roemer MGM, Redd RA, Cader FZ et al.<\/i> Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma. J Clin Oncol. 2018; 36: 942-950.","DOI":"10.1200\/JCO.2017.77.3994"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Johnson DB, Estrada MV, Salgado R et al.<\/i> Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1\/PD-L1 therapy. Nat Commun. 2016; 7: 10582.","DOI":"10.1038\/ncomms10582"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/61\/4\/61_21007\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T05:38:44Z","timestamp":1640410724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/61\/4\/61_21007\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.21007","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"21007"}}